SEC Form 4 · accession 0001209191-16-129527
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart A Arbuckle
Director
Period of report
Jun 22, 2016
Accepted (ET)
Jun 24, 2016 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.08 | Jun 22, 2016 | A | 20,000 | A | — | Jun 21, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option was granted on June 22, 2016. The shares underlying such option vest in full on the earlier of June 22, 2017 or immediately prior to the Corporation's 2017 annual meeting of stockholders, subject to the reporting person's continued service as a director of the Corporation through such date.